| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862639354P | 2018-03-06 | 2018-03-06 | |
| PCT/US2019/020933WO2019173465A1 (en) | 2018-03-06 | 2019-03-06 | Human papillomavirus vaccines and uses of the same |
| Publication Number | Publication Date |
|---|---|
| SG11202008539YAtrue SG11202008539YA (en) | 2020-10-29 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202008539YASG11202008539YA (en) | 2018-03-06 | 2019-03-06 | Human papillomavirus vaccines and uses of the same |
| Country | Link |
|---|---|
| US (1) | US20210024586A1 (en) |
| EP (1) | EP3762022A4 (en) |
| JP (2) | JP7581048B2 (en) |
| KR (1) | KR20200130339A (en) |
| CN (1) | CN112088015A (en) |
| AU (1) | AU2019231654A1 (en) |
| CA (1) | CA3092937A1 (en) |
| IL (2) | IL314393A (en) |
| SG (1) | SG11202008539YA (en) |
| WO (1) | WO2019173465A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019145792A1 (en)* | 2018-01-24 | 2019-08-01 | The Council Of The Queensland Institute Of Medical Research | Hpv immunotherapy |
| CA3092935A1 (en) | 2018-03-06 | 2019-09-12 | Precigen, Inc. | Hepatitis b vaccines and uses of the same |
| IL303113A (en)* | 2020-11-25 | 2023-07-01 | Precigen Inc | Human papillomavirus vaccines and their uses for human papillomavirus-related diseases |
| US20240390475A1 (en)* | 2023-05-22 | 2024-11-28 | Precigen, Inc. | Human papillomavirus vaccines and uses of the same |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN443995A0 (en)* | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
| US6001622A (en)* | 1995-12-21 | 1999-12-14 | Sunnybrook Health Science Centre | Integrin-linked kinase and its use |
| JP5475939B2 (en)* | 2002-12-20 | 2014-04-16 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | HPV-16 and HPV-18L1 VLP vaccine |
| EP2333066B1 (en)* | 2005-03-25 | 2015-02-18 | National Research Council of Canada | Method for isolation of soluble polypeptides |
| GB0710538D0 (en)* | 2007-06-01 | 2007-07-11 | Glaxo Group Ltd | Vaccine |
| MX362513B (en)* | 2010-03-23 | 2019-01-22 | Intrexon Corp | VECTORS THAT EXPRESS CONDITIONALLY THERAPEUTIC PROTEINS, HOSPED CELLS THAT INCLUDE VECTORS, AND USES OF THE SAME. |
| WO2013112549A1 (en)* | 2012-01-24 | 2013-08-01 | Sanford Research/USD | Polynucleotides for treating oncogenic viral polypeptide positive tumors |
| EP2855511B1 (en)* | 2012-05-29 | 2019-07-24 | GenVec, Inc. | Herpes simplex virus vaccine |
| BR112017002809A2 (en)* | 2014-08-15 | 2017-12-19 | Genexine Inc | Methods To Treat Cervical Cancer |
| CA3006779A1 (en)* | 2015-12-09 | 2017-06-15 | Admedus Vaccines Pty Ltd | Immunomodulating composition for treatment |
| EP3408395A4 (en)* | 2016-01-27 | 2019-12-11 | Advaxis, Inc. | IMMUNOTHERAPY BASED ON PERSONALIZED DELIVERY VECTORS AND USES THEREOF |
| US20190134195A1 (en)* | 2016-06-03 | 2019-05-09 | Etubics Corporation | Compositions and methods for the treatment of human papillomavirus (hpv)-associated diseases |
| Publication number | Publication date |
|---|---|
| KR20200130339A (en) | 2020-11-18 |
| EP3762022A1 (en) | 2021-01-13 |
| JP7581048B2 (en) | 2024-11-12 |
| EP3762022A4 (en) | 2022-06-15 |
| WO2019173465A1 (en) | 2019-09-12 |
| JP2021514667A (en) | 2021-06-17 |
| IL314393A (en) | 2024-09-01 |
| CA3092937A1 (en) | 2019-09-12 |
| US20210024586A1 (en) | 2021-01-28 |
| IL277129A (en) | 2020-10-29 |
| JP2023138959A (en) | 2023-10-03 |
| AU2019231654A1 (en) | 2020-10-01 |
| CN112088015A (en) | 2020-12-15 |
| Publication | Publication Date | Title |
|---|---|---|
| ZA202209472B (en) | Modulators of 5'-nucleotidase, ecto and the use thereof | |
| EP3720502A4 (en) | Cytobiologics and therapeutic uses thereof | |
| EP3487379A4 (en) | Medical devices and methods of use | |
| IL249162B (en) | Combination therapy of tumor-targeted il-2 variant immunocytokines and antibodies against human pd-l1 | |
| IL277129A (en) | Human papillomavirus vaccines and uses of the same | |
| EP3758778A4 (en) | Medical devices and uses thereof | |
| EP3814487A4 (en) | Structure of the human cgas-dna complex and uses thereof | |
| EP3133914A4 (en) | Continuous cooker stretcher and methods of use thereof | |
| IL283782A (en) | Anellosomes and methods of use | |
| EP3496804A4 (en) | Bioelectric devices and methods of use | |
| IL291180A (en) | Bee vaccines and methods of use | |
| GB201717123D0 (en) | Surgical tables and methods of operating the same | |
| GB201709840D0 (en) | Methods and medical uses | |
| IL277128A (en) | Hepatitis b vaccines and uses of the same | |
| EP3684406A4 (en) | Filovirus vaccine and methods of use | |
| EP3582792A4 (en) | Tissue stain and use thereof | |
| EP3599984A4 (en) | Endoscopes and methods of use | |
| EP3897691A4 (en) | Il-10-containing vaccines and uses thereof | |
| IL282142A (en) | 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament | |
| GB2600270B (en) | Polymer-comrprising medical devices and uses thereof | |
| PT3664800T (en) | Therapeutic formulations and uses thereof | |
| AU2025202716A1 (en) | Imidazodiazepinediones and methods of use thereof | |
| GB201806133D0 (en) | Methods and medical uses | |
| GB201808500D0 (en) | Virus and virus use | |
| GB201802743D0 (en) | Medicament and use thereof |